Someone who expects to lose 40 pounds on CJC-1295/Ipamorelin will be disappointed because that is not what the compound does
The benefit-risk profile generally favors use in appropriate patients, particularly given the cardiovascular and metabolic benefits demonstrated in outcome trials
There is a rare potential for urinary tract infection, or urinary catheterization or skin discoloration, however these are not encountered frequently
Cell therapy is still a developing field for fill/finish
Better deep sleep and improved sleep architecture (how your sleep is structured across cycles) can lead to better focus, mood support, improved cognitive function, and more consistent energy during waking hours
The PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP-1 receptor pathways, FTO gene expression, and appetite-signaling molecules that influence both weight loss outcomes and potential side-effect susceptibility